Wrinkles

... Allergan, the Makers of BOTOX(R), Receive UK Approval for VISTABEL for Cosmetic Use for the Treatment of Glabellar Lines (Vertical 'Frown' Lines Between the Brows) News Release Monday 13 March 2006, 0:01 GMT Monday 13 March 2006 HEALTH CONSUMER Allergan Ltd Allergan, the Makers of BOTOX(R), Receive UK Approval for VISTABEL for Cosmetic Use for the Treatment of Glabellar Lines (Vertical 'Frown' Lines Between the Brows) HIGH WYCOMBE, England, March 13 /PRNewswire/ - Allergan Ltd.

today announced that VISTABEL(R) (botulinum toxin type A) has been granted a licence in the UK from the Medicines and Healthcare products Regulatory Agency (MHRA) for the temporary improvement in the appearance of moderate to severe glabellar lines (vertical 'frown' lines between the brows) in adult women and men aged 65 and younger, when the severity of these lines has a psychological impact for the patient.

With dosing specific to treat glabellar lines, BOTOX(R) for cosmetic use will be marketed in the UK under the brand name VISTABEL(R) and is the first and only brand of botulinum toxin type A licensed for cosmetic use in the UK.

"VISTABEL(R) has proven to be an effective treatment option for minimising wrinkles between the brows, achieving a naturally refreshed and relaxed upper face rejuvenation that so many people are seeking today," said Dr Nick Lowe, Consultant Dermatologist, Cranley Clinic, London.

"The licensing of VISTABEL(R) reinforces that this is a product with an established safe...

Read more...